How to improve your clinic organization to ensure a better patient experience, and optimize adherence to treatment

Today my guest is Mr James Talks, Consultant Ophthalmologist at the Newcastle Eye Centre in Newcastle, UK. He joins me to discuss how clinic organization can impact adherence and persistence and what aspects we can modify to ensure a better patient experience and optimize adherence to treatment. Speaker disclosures:Professor Anat LoewensteinConsultancy, Research grants: Allergan, Bayer, Beyeonics Surgical, KHB, Novartis, Notal Vision, Oculis, Oxurion, Pres-By, Roche, Sensor, WebMD, Xbrane Mr James TalksConsultancy, Research grants: Allergan, Bayer,  Boehringer Ingelheim, Novartis, RocheJune 2025 | MA-PFM-OPHT-ALL-0646-1This podcast series is intended for HCPs, and is not intended for UK audiences. Always refer to local treatment guidelines and relevant prescribing information. Please review the product information before prescribing.This podcast series is produced and funded by Bayer Consumer Care AG. The views and opinions expressed throughout this podcast are the speakers' own, based on their clinical experience and expertise.The Barometer Program is managed by clinical leaders in ophthalmology as well as representatives from the IFA, IAPB and Bayer Consumer Care AG. The activities of the Barometer Program are funded and facilitated by Bayer Consumer Care AG where the scientists and representatives from IFA and IAPB retain decision authority to the research scope, methods, analysis of findings, and dissemination of the outputs of the Barometer Program.The Vision Academy is a group of over 80 international experts who, through their collective expertise, provide consensus guidance for managing clinically challenging situations, especially in areas of controversy or with insufficient conclusive evidence. The Vision Academy is funded and facilitated by Bayer Consumer Care AG. The opinions and guidance of the Vision Academy outputs are those of its members and do not necessarily reflect the opinions of Bayer Consumer Care AG.